1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with sulochrin in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (sulochrin) | Trials (sulochrin) | Recent Studies (post-2010) (sulochrin) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 22 | 0 | 7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukamachi, H; Gleich, GJ; Ishikawa, M; Kawai, H; Kita, H; Miura, T; Motegi, Y; Ohashi, H | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sulochrin
Article | Year |
---|---|
Sulochrin inhibits eosinophil activation and chemotaxis.
Topics: Animals; Anti-Allergic Agents; Benzoates; Cell Degranulation; Chemotaxis, Leukocyte; Eosinophils; Guinea Pigs; Humans; Immunoglobulin A; Immunoglobulin G; Interleukin-8; Leukotriene B4; Leukotriene C4; Platelet Activating Factor; Sepharose; Superoxides | 1998 |